Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
21 06 2020
Historique:
entrez: 23 6 2020
pubmed: 23 6 2020
medline: 16 2 2021
Statut: epublish

Résumé

With almost 50% of cases preventable and the Australian National Bowel Cancer Screening Program in place, colorectal cancer (CRC) is a prime candidate for investment to reduce the cancer burden. The challenge is determining effective ways to reduce morbidity and mortality and their implementation through policy and practice. Ethics approval was not required as human participants were not involved. Findings are reported in a series of papers in peer-reviewed journals and presented at fora to engage the community and policymakers.

Identifiants

pubmed: 32565470
pii: bmjopen-2019-036475
doi: 10.1136/bmjopen-2019-036475
pmc: PMC7307542
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e036475

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: KC, EF, JW, JBL, EH, MC, NT, KBu and HH receive salary support from CCNSW. KC is co-PI of unrelated investigator-initiated trial of cervical screening in Australia (‘Compass’) conducted by the Victorian Cytology Service, which has received funding contribution from Roche Molecular Systems and Ventana, USA.

Références

Eur J Oncol Nurs. 2017 Aug;29:135-147
pubmed: 28720260
Biomed Res Int. 2015;2015:928251
pubmed: 26525423
Med J Aust. 2020 Feb;212(2):72-81
pubmed: 31595523
Trials. 2019 Jun 20;20(1):373
pubmed: 31221211
J Clin Oncol. 2008 Dec 10;26(35):5783-8
pubmed: 18809606
Lancet Public Health. 2017 Feb;2(2):e96-e107
pubmed: 29253402
Cancer Treat Res. 2014;159:377-99
pubmed: 24114492
Clin Gastroenterol Hepatol. 2019 Oct;17(11):2294-2300.e1
pubmed: 30743005
Patient Relat Outcome Meas. 2015 May 18;6:127-38
pubmed: 26056501
BMJ Open. 2019 Jan 25;9(1):e024267
pubmed: 30813110
Lancet Oncol. 2012 May;13(5):518-27
pubmed: 22440112
Med J Aust. 2004 Jun 21;180(12):618-22
pubmed: 15200358
Med J Aust. 2007 Mar 19;186(6):292-5
pubmed: 17371209
Cancer Causes Control. 2008 Dec;19(10):1383-90
pubmed: 18704715
Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1450-1461
pubmed: 30190276
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt E):1-538
pubmed: 23193840
CA Cancer J Clin. 2015 Nov-Dec;65(6):428-55
pubmed: 26348643
Cancer Epidemiol Biomarkers Prev. 2019 Jan;28(1):83-90
pubmed: 30530848
Lancet Public Health. 2017 Jul;2(7):e331-e340
pubmed: 29253458
J Public Health (Oxf). 2012 Mar;34(1):37-45
pubmed: 21933796
Prev Med. 2018 Jan;106:185-193
pubmed: 29109015
PLoS One. 2019 May 1;14(5):e0205633
pubmed: 31042714
Int J Environ Res Public Health. 2014 Aug 14;11(8):8251-66
pubmed: 25153460
N Engl J Med. 2016 Aug 25;375(8):794-8
pubmed: 27557308
Sci Transl Med. 2019 Oct 9;11(513):
pubmed: 31597751
Public Health. 2020 Feb;179:90-99
pubmed: 31760206
BMC Cancer. 2016 Feb 01;16:48
pubmed: 26832359
Cochrane Database Syst Rev. 2009 Jul 08;(3):CD005392
pubmed: 19588372
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD003432
pubmed: 18425886
Med J Aust. 2014 Oct 20;201(8):435-6
pubmed: 25332018
Gynecol Oncol. 2019 Mar;152(3):465-471
pubmed: 30876490
Asia Pac J Clin Oncol. 2018 Feb;14(1):5-15
pubmed: 28929586
PLoS One. 2020 Feb 3;15(2):e0227899
pubmed: 32012174
Lancet Public Health. 2016 Dec;1(2):e66-e75
pubmed: 29253419
Eur J Cancer. 2005 Nov;41(17):2715-21
pubmed: 16230004
Clin Colorectal Cancer. 2016 Sep;15(3):195-203
pubmed: 26964802
BMC Public Health. 2009 May 15;9:144
pubmed: 19442312
Prev Med. 2017 Mar;96:135-143
pubmed: 27923667
J Gastrointest Oncol. 2018 Feb;9(1):160-169
pubmed: 29564182
BMC Cancer. 2018 Mar 27;18(1):339
pubmed: 29587660
Clin Genet. 2009 Jul;76(1):1-18
pubmed: 19659756
Int J Cancer. 2018 Jul 15;143(2):269-282
pubmed: 29441568
Med J Aust. 2018 Nov 19;209(10):455-460
pubmed: 30359558
Aust N Z J Public Health. 2015 Oct;39(5):477-84
pubmed: 26437735

Auteurs

Eleonora Feletto (E)

Cancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, Australia eleonoraf@nswcc.org.au.
School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

Jie-Bin Lew (JB)

Cancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, Australia.
School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

Joachim Worthington (J)

Cancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, Australia.
School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

Emily He (E)

Cancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, Australia.
School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

Michael Caruana (M)

Cancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, Australia.
School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

Katherine Butler (K)

Cancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, Australia.

Harriet Hui (H)

Cancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, Australia.

Natalie Taylor (N)

Cancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, Australia.
Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Emily Banks (E)

ANU College of Medicine, Biology and Environment, Australian National University, Canberra, Australian Capital Territory, Australia.

Karen Barclay (K)

Northern Clinical School, Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia.

Kate Broun (K)

Centre for Behavioural Research in Cancer, Cancer Council Victoria, Melbourne, Victoria, Australia.

Alison Butt (A)

Research Strategy Office, University of New South Wales, Sydney, New South Wales, Australia.

Rob Carter (R)

Deakin Institute for Health Research, Deakin University, Melbourne, Victoria, Australia.

Jeff Cuff (J)

Faculty of Science Biotech and Biomolecular Science, University of New South Wales, Sydney, New South Wales, Australia.
Research Advocate, Sydney, New South Wales, Australia.

Anita Dessaix (A)

Cancer Prevention and Advocacy, Cancer Council NSW, Woolloomooloo, New South Wales, Australia.

Hooi Ee (H)

Department of Gastroenterology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

Jon Emery (J)

General Practice and Primary Care Academic Centre, University of Melbourne, Carlton, Victoria, Australia.

Ian M Frayling (IM)

Inherited Tumour Syndromes Research Group, Division of Cancer & Genetics, Cardiff University, Cardiff, UK.

Paul Grogan (P)

Cancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, Australia.
School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

Carol Holden (C)

No Australians Dying of Bowel Cancer Initiative, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.

Christopher Horn (C)

Cancer Institute New South Wales, Eveleigh, New South Wales, Australia.

Mark A Jenkins (MA)

Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.

James G Kench (JG)

Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Maarit A Laaksonen (MA)

Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia.

Barbara Leggett (B)

Conjoint Gastroenterology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
School of Medicine, University of Queensland, Herston, Queensland, Australia.
Gastroenterology & Hepatology Department, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.

Gillian Mitchell (G)

Parkville Familial Cancer Centre, Peter MacCallum Cancer Institute, Melbourne, Victoria, Australia.
The Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

Susan Morris (S)

Research Advocate, Sydney, New South Wales, Australia.
Lynch Syndrome Australia, Brisbane, Queensland, Australia.

Bonny Parkinson (B)

Macquarie University Centre for the Health Economy, Macquarie University, Sydney, New South Wales, Australia.

D James St John (DJ)

Cancer Council Victoria, Melbourne, Victoria, Australia.
Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia.

Linda Taoube (L)

School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

Katherine Tucker (K)

Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia.
Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Melanie A Wakefield (MA)

Centre for Behavioural Research in Cancer, Cancer Council Victoria, Melbourne, Victoria, Australia.

Robyn L Ward (RL)

Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.

Aung Ko Win (AK)

Centre for Epidemiology and Biostatistics, The University of Melbourne, Parkville, Victoria, Australia.
Precision Prevention and Early Detection, University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Melbourne, Victoria, Australia.

Daniel L Worthley (DL)

No Australians Dying of Bowel Cancer Initiative, South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.

Bruce K Armstrong (BK)

School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

Finlay A Macrae (FA)

Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia.
Genetic Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.

Karen Canfell (K)

Cancer Research Division, Cancer Council NSW, Woolloomooloo, New South Wales, Australia.
School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH